Gregory Resch

Title: Innovations of Gregory Resch

Introduction

Gregory Resch is a notable inventor based in Evian les Bains, France. He has made significant contributions to the field of bacteriophage research, holding three patents that showcase his innovative work. His inventions focus on the development of dimeric bacteriophage lysins, which have important applications in combating bacterial infections.

Latest Patents

One of Gregory Resch's latest patents involves isolated dimeric-specific phage lysins. These lysins consist of two-specific phage lysin monomers that are covalently linked to each other. They exhibit killing activity against one or more bacteria. Additionally, the patent provides pharmaceutical compositions of dimeric lysins and outlines their use in therapeutic treatment or alleviation of infections or bacterial colonizations. The dimeric lysins can also be utilized to decontaminate both porous and non-porous surfaces or devices.

Career Highlights

Gregory Resch is affiliated with The Rockefeller University, where he conducts his research and development work. His innovative approach to bacteriophage lysins has positioned him as a key figure in the field of microbiology and therapeutic solutions.

Collaborations

Gregory Resch collaborates with Vincent A. Fischetti, a fellow researcher who shares his interest in bacteriophage technology and its applications.

Conclusion

Gregory Resch's work in developing dimeric bacteriophage lysins represents a significant advancement in the fight against bacterial infections. His contributions to the field are invaluable and highlight the importance of innovation in medical research.